Affimed N.V. (AFMD)
NASDAQ: AFMD · IEX Real-Time Price · USD
5.15
-0.29 (-5.33%)
At close: Jul 19, 2024, 4:00 PM
5.10
-0.05 (-0.97%)
Pre-market: Jul 22, 2024, 8:45 AM EDT
Affimed Employees
Affimed had 76 employees as of December 31, 2023. The number of employees decreased by 143 or -65.30% compared to the previous year.
Employees
76
Change (1Y)
-143
Growth (1Y)
-65.30%
Revenue / Employee
$56,064
Profits / Employee
-$1,331,951
Market Cap
78.42M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Alpha Teknova | 211 |
Protalix BioTherapeutics | 208 |
Hyperfine | 131 |
DBV Technologies | 105 |
Verastem | 73 |
Boundless Bio | 72 |
Chimerix | 72 |
BioAtla | 65 |
AFMD News
- 5 weeks ago - Affimed Reports First Quarter 2024 Financial Results & Business Update - GlobeNewsWire
- 6 weeks ago - Affimed to Report First Quarter 2024 Financial Results & Corporate Update on June 12, 2024 - GlobeNewsWire
- 7 weeks ago - Affimed Provides Follow-up Data of AFM24 plus Atezolizumab Showing Durable Responses in Heavily Pretreated NSCLC EGFR Wild-type Patients and Positive Initial Data from the NSCLC EGFR Mutant Cohort - GlobeNewsWire
- 7 weeks ago - Affimed Receives Fast Track Designation for Combination Therapy of AFM24 with Atezolizumab for EGFR Wild-Type Non-Small Cell Lung Cancer - GlobeNewsWire
- 7 weeks ago - Affimed Announces Annual General Meeting of Shareholders - GlobeNewsWire
- 2 months ago - Affimed Announces Positive Early Efficacy and Progression Free Survival Results of AFM24-102 Study in EGFR Wild-Type Non-Small Cell Lung Cancer at the Annual Meeting of the American Society of Clinical Oncology 2024 - GlobeNewsWire
- 2 months ago - Affimed Announces Acceptance of an Abstract on Preclinical Data of its Innate Cell Engager AFM28 at the European Hematology Association 2024 Congress - GlobeNewsWire
- 3 months ago - Affimed Announces Acceptance of AFM24 Clinical Abstract at the 2024 Annual Meeting of the American Society of Clinical Oncology - GlobeNewsWire